Scientific Advisors

Simon H. Stertzer, M.D., Director

Dr. Simon Stertzer, MD: Dr. Stertzer is currently the Director of Experimental Angioplasty, Clinical Professor of Medicine and Associate Director of International Medical Services at Stanford University School of Medicine. Dr. Stertzer received his MD from the NYU School of Medicine and interned in surgery at the University of California Hospitals, San Francisco. He served as Assistant Resident in Medicine at NYU and later as Chief Medical Resident at NYU Division of Bellevue Hospital. He had a fellowship at NYU Hospital in Cardiovascular Disease. His numerous academic and hospital appointments include Attending Cardiologist at NYU School of Medicine 1965-1983, Chief of the Hemodynamics Laboratory at Lenox Hill Hospital New York from 1971-1983, and Director of Medical Research, San Francisco Heart Institute, Seton Medical Center, Daly City, CA, 1983-1992. Dr. Stertzer pioneered the subspecialty of Interventional Cardiology and was the first to perform a coronary angioplasty in the United States. . Dr. Stertzer has performed more than 12,000 coronary interventions, and been visionary in his efforts working with others to develop new technologies for the improvement of patient care. He was a founder of numerous medical technology companies, including Arterial Vascular Engineering which was acquired by Medtronic, Quanum Medical which was acquired by Boston Scientific, and Vascular Science, Inc. which was acquired by St. Jude Medical. He has written, lectured and taught extensively about such new technologies as:Treatment of acute heart attacks with angioplasty, High speed Rotational Atherectomy, Stent treatment of Coronary Disease, Pacemaker Therapy, and Drug eluting devices for coronary restenosis.